PT-141 peptide dosage varies by form and person. Learn typical pt-141 dosage male and female ranges, spray and nasal options, timing, and safety.
The typical PT-141 peptide dosage is 1.25 mg to 1.75 mg injected subcutaneously about 45 minutes before sexual activity, and no more than one dose should be taken in a 24-hour period. The FDA-approved form, bremelanotide (Vyleesi), is labeled at 1.75 mg for premenopausal women with hypoactive sexual desire disorder. There is no FDA-approved PT-141 dose for men, so any male use is off-label.
What PT-141 Is and How Dosing Works
PT-141, also called bremelanotide, is a synthetic melanocortin receptor agonist. It acts on the central nervous system instead of blood vessels, which is why researchers describe it as a desire-related peptide rather than a vasodilator like Viagra.
Dosing is fixed rather than weight-based. The variable that matters most is the route of administration: subcutaneous injection, nasal spray, or a compounded sublingual liquid.
- Onset: about 30 to 60 minutes after injection
- Peak effect: roughly 1 to 2 hours
- Duration: up to about 4 hours
- Half-life: approximately 2.7 hours
Because of that timeline, most protocols call for dosing 45 minutes before anticipated sexual activity.
PT-141 Peptide Dosage Chart by Route
A pt-141 peptide dosage chart helps because each form delivers a very different amount of the drug. Only the subcutaneous injection has an FDA-approved dose.
| Route or Form | Typical Studied Dose | Timing | Notes |
|---|---|---|---|
| Subcutaneous injection (FDA-approved) | 1.75 mg | 45 minutes before activity | Maximum one dose per 24 hours and no more than 8 doses per month |
| Subcutaneous injection (lower trial dose) | 1.25 mg | 45 minutes before activity | Used in trials; smaller average effect but fewer side effects |
| Compounded nasal spray | About 10 mg in older research | 30 to 60 minutes before activity | Intranasal development was discontinued after blood pressure increases |
| Compounded sublingual or spray products | Labeled 1 mg to 10 mg | 30 to 60 minutes before activity | Not FDA-approved; actual content often differs from the label |
Starting Low and Adjusting
Many clinicians begin with 1.25 mg to see how a patient tolerates the peptide pt-141 dosage before moving up to 1.75 mg. Nausea is dose-dependent, so a lower starting dose often means fewer side effects.
PT-141 should not be used more than once in a 24-hour period, and the approved label caps use at eight doses per month. Higher doses have not been shown to improve results, and they increase the risk of nausea, flushing, and vomiting.
PT-141 Dosage for Women
Regulatory dosing is based on women. For pt-141 dosage for women, the approved regimen is 1.75 mg injected subcutaneously into the thigh or abdomen 45 minutes before sexual activity. Clinical trials also tested 1.25 mg, which helped some participants but produced a smaller average benefit.
Bremelanotide is approved only for premenopausal women with acquired, generalized hypoactive sexual desire disorder that causes marked distress. It is not approved for postmenopausal women or for people who simply want a temporary boost in desire.
PT-141 Dosage for Men
There is no FDA-approved pt-141 dosage male label, so male dosing comes from small studies and off-label practice rather than regulatory review. Reports commonly describe 1.75 mg subcutaneously, occasionally 2 mg, with the same 45-minute lead time.
Some online communities suggest doses above 2 mg, but there is no trial evidence showing better results at higher amounts. Men who research this peptide are usually also looking at testosterone therapy, PDE5 inhibitors, and lifestyle factors.
Spray and Nasal Formulations
Compounded pt-141 peptide nasal spray and sublingual sprays are sold widely online. The original intranasal version was studied at about 10 mg, but development stopped because of blood pressure increases and inconsistent absorption.
There is no standard dosage for compounded sprays. Products labeled "500 mcg per spray" or "10 mg per spray" vary enormously, and independent testing of compounded peptides has repeatedly found amounts that differ from the label.
Nasal and spray routes also produce more variable blood levels than injection, which makes them hard to compare with the 1.75 mg injected dose.
Safety, Side Effects, and Legal Status
Nausea is the most common side effect and affects up to 40% of people in trials. Flushing, headache, vomiting, fatigue, and injection site reactions are also frequently reported.
PT-141 can raise blood pressure temporarily. It is contraindicated for people with uncontrolled hypertension or known cardiovascular disease.
Repeated use has been linked to darkening of the gums, skin, and nails. This hyperpigmentation may not fully reverse after the drug is stopped.
In the United States, bremelanotide is a prescription drug. Compounded versions are not FDA-approved, and buying peptides from unregulated vendors carries risks of contamination, incorrect dosing, and unknown purity.
Anyone considering PT-141 should talk with a healthcare professional, particularly if they take blood pressure medication or have a history of heart problems.
Common Dosing Mistakes
- Redosing too soon instead of waiting a full 24 hours.
- Assuming a bigger dose works better when it mostly adds nausea.
- Using PT-141 daily rather than limiting it to eight doses per month.
- Following an online chart that confuses injection doses with nasal spray doses.
- Ignoring blood pressure changes or mixing PT-141 with other vasoactive drugs without medical guidance.
Frequently Asked Questions
What is the standard PT-141 dosage for adults?
The FDA-approved dose is 1.75 mg injected subcutaneously 45 minutes before sexual activity, with a maximum of one dose every 24 hours. Clinical trials also tested 1.25 mg, which produced a smaller average effect with fewer side effects. There is no approved PT-141 dose for men.
How long does PT-141 take to work?
PT-141 usually starts working within 30 to 60 minutes of injection and peaks around 1 to 2 hours. Effects can last up to about 4 hours. The half-life is roughly 2.7 hours, so the drug clears the body relatively quickly.
Can you use PT-141 more than once a day?
No. The label allows only one dose every 24 hours and no more than eight doses per month. Using it more often raises the risk of nausea, temporary blood pressure increases, and skin or gum hyperpigmentation.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.